Opus Genetics IRD
NASDAQ IRD
$4.58 +0.07 (+1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Net Preferred Shares Issued and Repurchased (2026)

Updated

Opus Genetics (IRD) reported Net Preferred Shares Issued and Repurchased of $25 million for Q1 2026.

Analysis

Opus Genetics (IRD) Net Preferred Shares Issued and Repurchased (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Opus Genetics 378.53 Mn 153.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25.00 Mn
API Access

Opus Genetics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=IRD&period=max&api_key=YOUR_API_KEY